Standout Papers

SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits 2024 202642
  1. SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits (2024)
    Alberto Preda, Fabrizio Montecucco et al. Cardiovascular Research

Immediate Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 21

Citing Papers

Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis
2024 Standout
Level of IL-6, TNF, and IL-1β and age-related diseases: a systematic review and meta-analysis
2024 Standout
2 intermediate papers

Works of Simon Kraler being referenced

Ageing and longevity genes in cardiovascular diseases
2020

Author Peers

Author Last Decade Papers Cites
Simon Kraler 336 153 125 149 42 677
Paola Songia 335 116 68 138 39 681
Μanolis Vavuranakis 310 190 84 122 60 709
Paola Vallerio 273 99 74 223 40 768
Ju‐Pin Pan 260 180 74 96 27 779
Tsun-Jui Liu 313 211 56 243 50 781
Konstantinos Mourouzis 202 132 67 205 38 638
Wei Zhang 250 90 64 180 54 798
Marina Zaromitidou 277 124 98 157 48 705
Tsukasa Inada 326 223 174 139 34 832
David Busseuil 347 173 103 245 54 834

All Works

Loading papers...

Rankless by CCL
2026